NM_006248.4(PRB2):c.688A>G (p.Asn230Asp) AND not specified

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: May 27, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV004077199.1

Allele description [Variation Report for NM_006248.4(PRB2):c.688A>G (p.Asn230Asp)]

NM_006248.4(PRB2):c.688A>G (p.Asn230Asp)

Gene:

PRB2:proline rich protein BstNI subfamily 2 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

12p13.2

Genomic location:

Preferred name:

NM_006248.4(PRB2):c.688A>G (p.Asn230Asp)

HGVS:

NC_000012.12:g.11393390T>C
NM_006248.4:c.688A>GMANE SELECT
NP_006239.3:p.Asn230Asp
NC_000012.11:g.11546324T>C
NM_006248.3:c.688A>G

Protein change:

N230D

Molecular consequence:

NM_006248.4:c.688A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: AllHighlyPenetrant
Identifiers:: MedGen: CN169374

Recent activity

Clear Turn Off Turn On

Rhinolophus simulator complex sp. 2 TD-2019 voucher FMNH:211999 rogdi-like prote...
Rhinolophus simulator complex sp. 2 TD-2019 voucher FMNH:211999 rogdi-like protein (ROGDI) gene, intron 7
gi|1735123587|gb|MN026049.1|

Nucleotide
Insemination, Artificial, Heterologous
Insemination, Artificial, Heterologous
Human artificial insemination in which the semen used is that of a man other than the woman's husband.<br/>Year introduced: 1991(1975)

MeSH
Patellofemoral Joint
Patellofemoral Joint
The articulation between the articular surface of the PATELLA and the patellar surface of the FEMUR.<br/>Year introduced: 2010

MeSH

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003531223	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (May 27, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003531223

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(May 27, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV003531223.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The c.688A>G (p.N230D) alteration is located in exon 3 (coding exon 3) of the PRB2 gene. This alteration results from a A to G substitution at nucleotide position 688, causing the asparagine (N) at amino acid position 230 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Nov 3, 2024

ClinVar

Relating variation to medicine